Agricultural Farm Products
Compare Stocks
4 / 10Stock Comparison
CHSCL vs CALM vs ADM vs BG
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Farm Products
Agricultural Farm Products
Agricultural Farm Products
CHSCL vs CALM vs ADM vs BG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Agricultural Farm Products | Agricultural Farm Products | Agricultural Farm Products | Agricultural Farm Products |
| Market Cap | — | $3.61B | $37.36B | $24.02B |
| Revenue (TTM) | $35.03B | $4.21B | $80.61B | $80.54B |
| Net Income (TTM) | $614M | $1.15B | $1.08B | $686M |
| Gross Margin | 3.2% | 41.9% | 5.8% | 5.2% |
| Operating Margin | 0.2% | 34.8% | 1.5% | 2.4% |
| Forward P/E | — | 9.4x | 18.6x | 14.4x |
| Total Debt | $3.23B | $0.00 | $8.41B | $16.95B |
| Cash & Equiv. | $399M | $500M | $1.01B | $1.14B |
CHSCL vs CALM vs ADM vs BG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| CHS Inc. (CHSCL) | 100 | 95.8 | -4.2% |
| Cal-Maine Foods, In… (CALM) | 100 | 170.0 | +70.0% |
| Archer-Daniels-Midl… (ADM) | 100 | 197.2 | +97.2% |
| Bunge Global S.A. (BG) | 100 | 317.3 | +217.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHSCL vs CALM vs ADM vs BG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHSCL is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.10, Low D/E 29.1%, current ratio 1.53x
- Beta 0.10 vs BG's 0.25, lower leverage
CALM carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 83.2%, EPS growth 338.5%, 3Y rev CAGR 33.9%
- 83.2% revenue growth vs CHSCL's -9.7%
- Lower P/E (9.4x vs 14.4x)
- 27.4% margin vs BG's 0.9%
ADM is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 31 yrs, beta 0.12, yield 2.6%
- 147.4% 10Y total return vs BG's 140.3%
- Beta 0.12, yield 2.6%, current ratio 11.20x
BG is the clearest fit if your priority is momentum.
- +66.8% vs CALM's -15.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 83.2% revenue growth vs CHSCL's -9.7% | |
| Value | Lower P/E (9.4x vs 14.4x) | |
| Quality / Margins | 27.4% margin vs BG's 0.9% | |
| Stability / Safety | Beta 0.10 vs BG's 0.25, lower leverage | |
| Dividends | 8.9% yield, 1-year raise streak, vs ADM's 2.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +66.8% vs CALM's -15.7% | |
| Efficiency (ROA) | 36.7% ROA vs BG's 1.6%, ROIC 63.6% vs 3.3% |
CHSCL vs CALM vs ADM vs BG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CHSCL vs CALM vs ADM vs BG — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CALM leads in 4 of 6 categories
CHSCL leads 1 • ADM leads 0 • BG leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CALM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ADM is the larger business by revenue, generating $80.6B annually — 19.1x CALM's $4.2B. CALM is the more profitable business, keeping 27.4% of every revenue dollar as net income compared to BG's 0.9%. On growth, BG holds the edge at +87.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $35.0B | $4.2B | $80.6B | $80.5B |
| EBITDAEarnings before interest/tax | $471M | $1.6B | $3.0B | $2.8B |
| Net IncomeAfter-tax profit | $614M | $1.2B | $1.1B | $686M |
| Free Cash FlowCash after capex | $280M | $1.2B | $4.8B | $112M |
| Gross MarginGross profit ÷ Revenue | +3.2% | +41.9% | +5.8% | +5.2% |
| Operating MarginEBIT ÷ Revenue | +0.2% | +34.8% | +1.5% | +2.4% |
| Net MarginNet income ÷ Revenue | +1.8% | +27.4% | +1.3% | +0.9% |
| FCF MarginFCF ÷ Revenue | +0.8% | +27.8% | +6.0% | +0.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.6% | -19.4% | +1.6% | +87.8% |
| EPS Growth (YoY)Latest quarter vs prior year | — | -52.3% | +1.6% | -76.4% |
Valuation Metrics
CALM leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 3.0x trailing earnings, CALM trades at a 91% valuation discount to ADM's 34.8x P/E. On an enterprise value basis, CALM's 1.9x EV/EBITDA is more attractive than BG's 22.6x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | — | $3.6B | $37.4B | $24.0B |
| Enterprise ValueMkt cap + debt − cash | — | $3.1B | $44.8B | $39.8B |
| Trailing P/EPrice ÷ TTM EPS | — | 3.04x | 34.77x | 25.16x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 9.39x | 18.63x | 14.38x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.02x | — | — |
| EV / EBITDAEnterprise value multiple | — | 1.91x | 17.18x | 22.60x |
| Price / SalesMarket cap ÷ Revenue | — | 0.85x | 0.47x | 0.34x |
| Price / BookPrice ÷ Book value/share | — | 1.44x | 1.63x | 1.18x |
| Price / FCFMarket cap ÷ FCF | — | 3.38x | 8.89x | — |
Profitability & Efficiency
CALM leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
CALM delivers a 42.7% return on equity — every $100 of shareholder capital generates $43 in annual profit, vs $4 for BG. CHSCL carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to BG's 0.97x. On the Piotroski fundamental quality scale (0–9), CALM scores 7/9 vs BG's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.5% | +42.7% | +4.7% | +4.3% |
| ROA (TTM)Return on assets | +3.0% | +36.7% | +2.2% | +1.6% |
| ROICReturn on invested capital | +0.5% | +63.6% | +3.3% | +3.3% |
| ROCEReturn on capital employed | +0.7% | +64.5% | +4.2% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 6 | 2 |
| Debt / EquityFinancial leverage | 0.29x | — | 0.37x | 0.97x |
| Net DebtTotal debt minus cash | $2.8B | -$500M | $7.4B | $15.8B |
| Cash & Equiv.Liquid assets | $399M | $500M | $1.0B | $1.1B |
| Total DebtShort + long-term debt | $3.2B | $0 | $8.4B | $17.0B |
| Interest CoverageEBIT ÷ Interest expense | 5.03x | 3042.99x | 3.03x | 3.10x |
Total Returns (Dividends Reinvested)
CALM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CALM five years ago would be worth $25,154 today (with dividends reinvested), compared to $12,144 for CHSCL. Over the past 12 months, BG leads with a +66.8% total return vs CALM's -15.7%. The 3-year compound annual growth rate (CAGR) favors CALM at 22.4% vs ADM's 3.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.0% | -2.1% | +32.2% | +34.4% |
| 1-Year ReturnPast 12 months | +7.4% | -15.7% | +66.2% | +66.8% |
| 3-Year ReturnCumulative with dividends | +22.2% | +83.5% | +10.7% | +46.3% |
| 5-Year ReturnCumulative with dividends | +21.4% | +151.5% | +29.2% | +49.4% |
| 10-Year ReturnCumulative with dividends | +59.2% | +94.6% | +147.4% | +140.3% |
| CAGR (3Y)Annualised 3-year return | +6.9% | +22.4% | +3.4% | +13.5% |
Risk & Volatility
CHSCL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CHSCL is the less volatile stock with a 0.10 beta — it tends to amplify market swings less than BG's 0.25 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHSCL currently trades 98.5% from its 52-week high vs CALM's 59.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.10x | 0.16x | 0.12x | 0.25x |
| 52-Week HighHighest price in past year | $26.10 | $126.40 | $81.75 | $133.93 |
| 52-Week LowLowest price in past year | $25.15 | $71.92 | $46.81 | $71.60 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +59.9% | +94.8% | +92.4% |
| RSI (14)Momentum oscillator 0–100 | 57.0 | 45.9 | 68.4 | 51.8 |
| Avg Volume (50D)Average daily shares traded | 26K | 844K | 3.8M | 1.7M |
Analyst Outlook
Evenly matched — CALM and ADM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CALM as "Hold", ADM as "Hold", BG as "Buy". Consensus price targets imply 12.2% upside for CALM (target: $85) vs -22.6% for ADM (target: $60). For income investors, CALM offers the higher dividend yield at 8.92% vs BG's 2.23%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $85.00 | $60.00 | $133.67 |
| # AnalystsCovering analysts | — | 8 | 36 | 25 |
| Dividend YieldAnnual dividend ÷ price | — | +8.9% | +2.6% | +2.2% |
| Dividend StreakConsecutive years of raises | — | 1 | 31 | 5 |
| Dividend / ShareAnnual DPS | — | $6.76 | $2.04 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | — | +1.5% | 0.0% | +2.3% |
CALM leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). CHSCL leads in 1 (Risk & Volatility). 1 tied.
CHSCL vs CALM vs ADM vs BG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CHSCL or CALM or ADM or BG a better buy right now?
For growth investors, Cal-Maine Foods, Inc.
(CALM) is the stronger pick with 83. 2% revenue growth year-over-year, versus -9. 7% for CHS Inc. (CHSCL). Cal-Maine Foods, Inc. (CALM) offers the better valuation at 3. 0x trailing P/E (9. 4x forward), making it the more compelling value choice. Analysts rate Bunge Global S. A. (BG) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHSCL or CALM or ADM or BG?
On trailing P/E, Cal-Maine Foods, Inc.
(CALM) is the cheapest at 3. 0x versus Archer-Daniels-Midland Company at 34. 8x. On forward P/E, Cal-Maine Foods, Inc. is actually cheaper at 9. 4x.
03Which is the better long-term investment — CHSCL or CALM or ADM or BG?
Over the past 5 years, Cal-Maine Foods, Inc.
(CALM) delivered a total return of +151. 5%, compared to +21. 4% for CHS Inc. (CHSCL). Over 10 years, the gap is even starker: ADM returned +147. 4% versus CHSCL's +59. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHSCL or CALM or ADM or BG?
By beta (market sensitivity over 5 years), CHS Inc.
(CHSCL) is the lower-risk stock at 0. 10β versus Bunge Global S. A. 's 0. 25β — meaning BG is approximately 158% more volatile than CHSCL relative to the S&P 500. On balance sheet safety, CHS Inc. (CHSCL) carries a lower debt/equity ratio of 29% versus 97% for Bunge Global S. A. — giving it more financial flexibility in a downturn.
05Which is growing faster — CHSCL or CALM or ADM or BG?
By revenue growth (latest reported year), Cal-Maine Foods, Inc.
(CALM) is pulling ahead at 83. 2% versus -9. 7% for CHS Inc. (CHSCL). On earnings-per-share growth, the picture is similar: Cal-Maine Foods, Inc. grew EPS 338. 5% year-over-year, compared to -38. 9% for Archer-Daniels-Midland Company. Over a 3-year CAGR, CALM leads at 33. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CHSCL or CALM or ADM or BG?
Cal-Maine Foods, Inc.
(CALM) is the more profitable company, earning 28. 6% net margin versus 1. 2% for Bunge Global S. A. — meaning it keeps 28. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CALM leads at 36. 1% versus 0. 3% for CHSCL. At the gross margin level — before operating expenses — CALM leads at 43. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CHSCL or CALM or ADM or BG more undervalued right now?
On forward earnings alone, Cal-Maine Foods, Inc.
(CALM) trades at 9. 4x forward P/E versus 18. 6x for Archer-Daniels-Midland Company — 9. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CALM: 12. 2% to $85. 00.
08Which pays a better dividend — CHSCL or CALM or ADM or BG?
In this comparison, CALM (8.
9% yield), ADM (2. 6% yield), BG (2. 2% yield) pay a dividend. CHSCL does not pay a meaningful dividend and should not be held primarily for income.
09Is CHSCL or CALM or ADM or BG better for a retirement portfolio?
For long-horizon retirement investors, Archer-Daniels-Midland Company (ADM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
12), 2. 6% yield, +147. 4% 10Y return). Both have compounded well over 10 years (ADM: +147. 4%, CHSCL: +59. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CHSCL and CALM and ADM and BG?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CHSCL is a small-cap quality compounder stock; CALM is a small-cap high-growth stock; ADM is a mid-cap quality compounder stock; BG is a mid-cap high-growth stock. CALM, ADM, BG pay a dividend while CHSCL does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Consumer Defensive
- Market Cap > $100B
- Revenue Growth > 43%
- Dividend Yield > 0.8%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.